- Psychedelics Legality and Ethics in Colorado: Where We Are vs. Where We Want to Be - December 20, 2024
- Lessons from the Massachusetts Ballot Campaign: What Happened and What’s Next? - December 13, 2024
- The Fight to Advance Psilocybin Therapy for Life-Threatening Conditions - November 22, 2024
Wednesday, March 27th, 2024 from 12:00-1:30pm PST
Register for this event here.
Join us as we discuss the HOPE Consensus Statement. This pioneering document aims to help steer the future of psychedelics with a strong ethical compass, highlighting psychedelic experiences beyond their medical use, advocating for essential aftercare in clinical trials, and exploring the innovative use in couples therapy. It’s a call to action for everyone interested in the ethical advancement of the psychedelic field. Join our speakers Brian D. Earp, philosopher and neuroethicist based at Oxford, and Eddie Jacobs, Research Fellow at the University of Oxford’s Wellcome Centre for Ethics and Humanities for this compelling Community Forum.
Brian D. Earp is a philosopher and neuroethicist based at Oxford with more than 10 years of research experience in psychedelic ethics. Brian is Director of the Oxford Centre for Neuroethics and Society, Co-Director of the Oxford Experimental Bioethics Lab, and Associate Director of the Yale-Hastings Program in Ethics and Health Policy. Brian holds a PhD from Yale University in philosophy and psychology, an MSc from Oxford in experimental psychology, and an MPhil from Cambridge University in the history, philosophy, and sociology of science, technology, and medicine. Brian is co-author of Love Drugs: The Chemical Future of Relationships (Stanford U. Press, 2020), the first mainstream book focused on the ethics of psychedelic-assisted couples therapy.
Eddie Jacobs is a Research Fellow at the University of Oxford’s Wellcome Centre for Ethics and Humanities, and a PhD student at the Department of Psychiatry, where his current research seeks to outline the novel ethical challenges posed by psychedelic-assisted psychotherapy, how these challenges might best be met, and how the unusual aspects of psychedelic healing invite a reconsideration of frameworks of psychiatric practice. Having entered the psychedelic space in January 2018 as Science Officer at the Beckley Foundation, a UK-based NGO that undertakes both scientific and policy work related to psychedelics, he has since supported other initiatives focused on developing ethical practice in the field, including Drug Science’s Medical Psychedelics Ethics Consortium, and leading the development of the Hopkins-Oxford Consensus Statement on Psychedelic Ethics.
This talk will be recorded and immediately available for rewatch for all attendees.
Do you love Chacruna? Want free entry to events, access to our online member community and exclusive events, free merchandise, and much more! Become a member!
Scholarships Available – apply here.
Take a minute to browse our stock:
Did you enjoy reading this article?
Please support Chacruna's work by donating to us. We are an independent organization and we offer free education and advocacy for psychedelic plant medicines. We are a team of dedicated volunteers!
Can you help Chacruna advance cultural understanding around these substances?
Become a Chacruna Member
To make a direct donation click the button below:
